TAT and Kaposi's sarcoma: The most extensively examined impact of Tat-mediated EC activation and dysfunction in HIV-1 infection is in the context of HIV-associated neurocognitive disorders (HAND) and HIV-associated cardiovascular or angio-proliferative disorders (including Kaposi's sarcoma).